Gutman, J. A., Winters, A., Kent, A., Amaya, M., McMahon, C., Smith, C., Jordan, C. T., Stevens, B., Minhajuddin, M., Pei, S., Schowinsky, J., Tobin, J., O’Brien, K., Falco, A., Taylor, E., Brecl, C., Zhou, K., Ho, P., Sohalski, C., Dell-Martin, J., Ondracek, O., Abbott, D. and Pollyea, D. A. (2023) “Higher-dose venetoclax with measurable residual disease-guided azacitidine discontinuation in newly diagnosed acute myeloid leukemia”, Haematologica. Pavia, Italy, 108(10), pp. 2616-2625. doi: 10.3324/haematol.2023.282681.